Dihydropyridine calcium-channel-blockers (DCCBs), used to treat high blood pressure, could speed up the progression of kidney ...
Bio Preventive Medicine Corp. and Precision Diabetes, Inc. today announced presentation of a Late-Breaking Abstract at the ...
New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be ...
In adults with type 2 diabetes and nephrotic-range proteinuria, SGLT2 inhibitors are linked to lower risks for major adverse ...
The results support the potential to change the trajectory of kidney function decline and extend life expectancy.
Everyday Health on MSN
Ozempic eases daily living for people with kidney disease
People with diabetes and kidney disease reported the equivalent of 8 extra days of full health per year when they took the ...
Key Takeaways Common blood pressure meds might increase risk of kidney damage among people with type 2 ...
Inside the human body, a silent battle rages between diabetes and kidney function, with devastating consequences many never see coming. Recent medical research has uncovered alarming evidence about ...
Bayer (XTRA:BAYN) reported first full Phase III results from the FIND-CKD trial of KERENDIA in non-diabetic chronic kidney ...
A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves ...
The drug finerenone significantly slows the decline in kidney function in patients with chronic kidney disease (CKD) who do ...
Finerenone reduced kidney function decline and cardiovascular-kidney events in non-diabetic CKD. Find out more from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results